ADVISORS
Daniel A. Culver, DO
Daniel A. Culver, DO, Advisor, is the director of the Interstitial Lung Disease Program at Cleveland Clinic. He has directed the Sarcoidosis Center of Excellence at Cleveland Clinic since 2005, and holds full staff appointments in the Department of Pulmonary Medicine and the Department of Pathobiology. He is the Chair of the Scientific Advisory Committee of the Foundation for Sarcoidosis Research, and a member of the Executive Committee for the Americas Association of Sarcoidosis and Other Granulomatous Disorders. He is the Chief Research Officer for the Respiratory Institute at Cleveland Clinic. He is a past recipient of the Bruce Hubbard Stewart Award and the HCOM Medal of Merit. He is a member of the ATS, ACCP, WASOG, and AASOG. His main interests include sarcoidosis, idiopathic pulmonary fibrosis, other granulomatous disease, pulmonary alveolar proteinosis and other interstitial diseases.
ABOUT SARCOMED USA
SarcoMedUSA was formed to investigate if an inhaled DNase 1 therapy could influence the chronic pulmonary inflammation seen in Pulmonary Sarcoidosis patients.Proof‐of‐Concept study in Kazakhstan.